In today’s global landscape, last century’s compliance frameworks, work flows, and SOPs serve as an anchor dragging down traditional big pharma:
“Investor pressure is on for us to streamline our compliance activities and reduce overhead. And yet we still have to abide by FDA, EMA, MHRA, and dozens more regulatory health agencies. We struggled to bridge where we were versus where we needed to go. Mr. Avellanet came in, gave us a realistic plan we could all agree to, and in four months, we were finally on our way after nearly two years of struggling internally and with other consultants. Cerulean really brings the insights and practical experience needed.”
– Regulatory Affairs Senior Director, Multi-National Pharmaceutical Company, Iselin, New Jersey